Targeting intermediates of the PRMT5/BRG1 axis as a combination therapy

被引：0
|
作者：
Shaykevich, Aaron
Silverman, Isaac
Siegman, Alexander
Maitra, Radhashree
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-1651
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1651
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Protein Arginine Methyltransferase 5 (PRMT5) and the ERK1/2 & PI3K Pathways: A Case for PRMT5 Inhibition and Combination Therapies in Cancer
    Sapir, Tzuriel
    Shifteh, David
    Pahmer, Moshe
    Goel, Sanjay
    Maitra, Radhashree
    MOLECULAR CANCER RESEARCH, 2021, 19 (03) : 388 - 394
  • [22] Targeting prmt5 inhibits DNA repair and enhances the radiosensitivity of GBM cells
    Degorre, Charlotte M.
    Lohard, Steven
    Tofilon, Philip J.
    CANCER RESEARCH, 2023, 83 (07)
  • [23] Targeting PRMT5 to Circumvent Acquired Ibrutinib Resistance in Mantle Cell Lymphoma
    Sloan, Shelby
    Brown, Fiona
    Chung, Ji Hyun
    Prouty, Alexander
    Wheeler, Esther
    Harrington, Bonnie K.
    Brooks, Eric
    Yilmaz, Ayse S.
    Ozer, Hatice G.
    Byrd, John C.
    Chen-Kiang, Selina
    Di Liberto, Maurizio
    Lapalombella, Rosa
    Vaddi, Kris
    Scherle, Peggy
    Youssef, Youssef
    Baiocchi, Robert A.
    Alinari, Lapo
    BLOOD, 2019, 134
  • [24] Targeting PRMT5 enhances the radiosensitivity of tumor cells grown in vitro and in vivo
    Degorre, Charlotte
    Lohard, Steven
    Bobrek, Christina N.
    Rawal, Komal N.
    Kuhn, Skyler
    Tofilon, Philip J.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [25] Effects of substrate modifications on the arginine dimethylation activities of PRMT1 and PRMT5
    Fulton, Melody D.
    Dang, Tran
    Brown, Tyler
    Zheng, Y. George
    EPIGENETICS, 2022, 17 (01) : 1 - 18
  • [26] M-TAP Dance: Targeting PRMT1 and PRMT5 Family Members to Push Cancer Cells Over the Edge
    Srour, Nivine
    Mersaoui, Sofiane Y.
    Richard, Stephane
    CANCER CELL, 2019, 36 (01) : 3 - 5
  • [27] Isolation of an scFv targeting BRG1 using phage display with characterization by AFM
    Marcus, WD
    Wang, H
    Lohr, D
    Sierks, MR
    Lindsay, SM
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 342 (04) : 1123 - 1129
  • [28] MTAP deletions in cancer create vulnerability to a MAT2A/PRMT5/RIOK1 axis
    Marks, Kevin
    CANCER RESEARCH, 2016, 76
  • [29] Targeting PRMT5 through PROTAC for the treatment of triple-negative breast cancer
    Guo, Yaxun
    Li, Yuzhan
    Zhou, Zhongmei
    Hou, Lei
    Liu, Wenjing
    Ren, Wenlong
    Mi, Dazhao
    Sun, Jian
    Dai, Xueqin
    Wu, Yingying
    Cheng, Zhuo
    Wu, Tingyue
    Luo, Qianmei
    Tian, Cong
    Li, Fubing
    Yu, Zhigang
    Chen, Yihua
    Chen, Ceshi
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2024, 43 (01)
  • [30] Targeting the chromatin remodeling protein BRG1 in liver fibrosis: Mechanism and translational potential
    Zhu, Yuwen
    Guo, Yan
    Xue, Yujia
    Zhou, Anqi
    Chen, Ying
    Chen, Yifei
    Miao, Xiulian
    Lv, Fangqiao
    LIFE SCIENCES, 2024, 336
12345